-transparent.png){kind=logo}
Anti-HCV was tested in 77 uremic patients, 48 on hemodialysis (HD), 29 on CAPD, by immunoenzymatic 1st and 2nd generation assays (ELISA I, II) and 4-antigen (4-RIBA) immublotting. The investigation was extended to the staff (n = 29) and to HCV-positive patients' families (n = 30). The prevalence using 2nd generation tests was double (21%) that in 1st generation tests (11%). A greater incidence in the HD than in the CAPD group (23 vs. 17%) and a highly significative correlation to dialytic age were observed. No one among the sanitary personnel and only 2 family members were found HCV positive, suggesting a low infectivity via the parenteral inevident route. Extracorporeal circulation and particularly the exposure time to the treatment seem to be the main risk factors.
P Cantù, and
S Mangano, and
M Masini, and
A Limido, and
G Crovetti, and
C DeFilippo
February 1993,
Revista medica de Chile,
P Cantù, and
S Mangano, and
M Masini, and
A Limido, and
G Crovetti, and
C DeFilippo
January 1991,
American journal of nephrology,
P Cantù, and
S Mangano, and
M Masini, and
A Limido, and
G Crovetti, and
C DeFilippo
January 1995,
G.E.N,
P Cantù, and
S Mangano, and
M Masini, and
A Limido, and
G Crovetti, and
C DeFilippo
April 1992,
Hepato-gastroenterology,
P Cantù, and
S Mangano, and
M Masini, and
A Limido, and
G Crovetti, and
C DeFilippo
January 1993,
Medicina clinica,
P Cantù, and
S Mangano, and
M Masini, and
A Limido, and
G Crovetti, and
C DeFilippo
April 1993,
Casopis lekaru ceskych,
P Cantù, and
S Mangano, and
M Masini, and
A Limido, and
G Crovetti, and
C DeFilippo
January 1992,
Nephron,
P Cantù, and
S Mangano, and
M Masini, and
A Limido, and
G Crovetti, and
C DeFilippo
July 1993,
Clinical nephrology,
P Cantù, and
S Mangano, and
M Masini, and
A Limido, and
G Crovetti, and
C DeFilippo
November 1999,
European journal of gastroenterology & hepatology,
P Cantù, and
S Mangano, and
M Masini, and
A Limido, and
G Crovetti, and
C DeFilippo
January 1996,
Acta gastroenterologica Latinoamericana,
